This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange gained 4.45 points to 797.59 Friday, ending the week up 3.08 points. Casper Bych's suspended, five-year-old capital pool shell, Zidane Capital Corp. (ZZE), is getting that jilted feeling. It is suing its qualifying transaction target, an aspiring medical cannabis producer in Ontario called HydRx Farms Ltd. According to Zidane, HydRx has breached their January, 2016, amalgamation agreement by secretly forming a plan to merge with another company, CannScience Innovations Inc. Neither HydRx nor CannScience has announced this supposed merger plan. Zidane says HydRx informed it of the plan last month. The shell has filed its notice of civil claim with the Supreme Court of British Columbia in Vancouver.

HydRx Farms, which also calls itself HydRx Pharma, owns a 44,000-square-foot medical marijuana production facility in Whitby, Ont. The facility includes a chemistry lab, a bio lab and a bio waste incinerator. While waiting for a cannabis production licence, HydRx offers lab testing services, as well as incineration services for clinical waste and pharmaceutical waste (including contaminated marijuana products and cannabis plant roots). HydRx and Zidane Capital had agreed that the shell would roll back 1 for 2.5, leaving it with 855,620 postconsolidated shares issued, then issue 12,900,896 postconsolidated shares to HydRx's shareholders. As a condition for closing the deal, HydRx needed to receive its marijuana production licence.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS